The FDA has approved Tagrisso (osimertinib)​ to treat patients with unresectable, stage III, EGFR-mutant NSCLC whose disease has not progressed during or after chemoradiotherapy.

In the years since targeted treatments for CLL were introduced, their use in the second line has increased, but chemotherapy regimens remain the most common first-line treatment in these patients.

(HealthDay News) — Most Americans don’t plan to get vaccinated against the flu or COVID-19 this season, according to a survey from the National Foundation for Infectious Diseases (NFID).

Patients who achieved a pathologic complete response after neoadjuvant therapy had better survival outcomes than patients who received adjuvant therapy.

The incidence of cardiovascular disease is higher in older adults with cancer, especially those with hematologic, lung, and metastatic cancers.

(HealthDay News) — A wearable device may improve physical activity, physical function, dyspnea, and pain after lung cancer surgery, according to a study published in JAMA Network Open.

Survey results suggest that cancer patients want financial toxicity screening to occur early, but screening preferences and practices vary.

Multiple myeloma patients with COVID-19 have high rates of hospitalization, ICU admission, and death, according to researchers.

Researchers sought to determine the effect of antibiotics on the risk of colorectal cancer recurrence after surgery.

Perioperative pembrolizumab can improve OS when combined with neoadjuvant chemotherapy in patients with high risk, ...

Trimodal therapy may be an effective alternative to radical cystectomy for recurrent, high-grade T1 bladder cancer, according to a study published in the Journal of Clinical Oncology.

People in the US have the shortest lives and the most avoidable deaths, ranking last on 5 out of 6 health outcome measures. Americans face the most barriers to obtaining health care. About 25 million ...